Mrcf
Finance · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
31 Queen St L 9, Melbourne, Victoria, 30...Phone Number
+61 396570700Website
www.mrcf.com.auRevenue
$12.2 MillionIndustry
About Mrcf
Mrcf Org Chart
Is Mrcf your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mrcf is spiking on competitors!
Mrcf, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Mrcf recently announced quarterly report
Product Launch: Get notified when Mrcf launches new products
Congratulate Masked Content for being promoted to Masked Content at Mrcf
Website visits: Recent activity has been detected on your website
Check if Mrcf has recently received funding, and reach out quickly before it becomes old news!
Click to see if Mrcf had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Mrcf has new funding data
Recommended Actions
Reach out to Masked Content who joined Mrcf as Masked Content
Find 3 more new buyers
Compare Similar Companies to Mrcf
Compare insights from companies similar to Mrcf, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mrcf is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Mrcf is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Mrcf.
Mrcf Tech Stack
A closer look at the technologies used by Mrcf
Mrcf News & Media
Pathios closes US$8.8M Series A and appoints Stuart Hughes as CEO. The financing will ...
Pathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEOThe financing will accelerate the development of first-in-class therapies in autoimmune disease and immuno-oncologyPathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO
Pathios Therapeutics Limited ("Pathios"), an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia's MedicalPathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO
Pathios Therapeutics Limited ("Pathios"), an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia's Medical Research Commercialisation Fund managed by Brandon Capital ("MRCF").
Top Finance Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Mrcf
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand, specializing in transforming biomedical research discoveries into medical products that enhance patient outcomes and save lives. The organization collaborates with major Australian superannuation funds, government bodies, and over 50 leading medical resear... Read More